VA-GLA Infectious Diseases
  • Home
  • News
  • Services
  • ASP Main Page Antibiotic Approvals Antibiotics Restricted to Guidelines Switching from IV to PO Antibiotic Timeouts Rapid Diagnostics at GLA ID in seconds
  • GLA Guidelines Needlestick Injury TB Isolation
  • Susceptibilities
  • ID fellow resources
  • Links Board Review slides Teaching Documents

VA-GLA Infectious Diseases

  • Home/
  • News/
  • Services/
  • Stewardship/
    • ASP Main Page
    • Antibiotic Approvals
    • Antibiotics Restricted to Guidelines
    • Switching from IV to PO
    • Antibiotic Timeouts
    • Rapid Diagnostics at GLA
    • ID in seconds
  • Guidelines/
    • GLA Guidelines
    • Needlestick Injury
    • TB Isolation
  • Susceptibilities/
  • ID fellow resources/
  • Other/
    • Links
    • Board Review slides
    • Teaching Documents

VA-GLA Infectious Diseases

VA-GLA Infectious Diseases

New and Noteworthy

VA-GLA Infectious Diseases

  • Home/
  • News/
  • Services/
  • Stewardship/
    • ASP Main Page
    • Antibiotic Approvals
    • Antibiotics Restricted to Guidelines
    • Switching from IV to PO
    • Antibiotic Timeouts
    • Rapid Diagnostics at GLA
    • ID in seconds
  • Guidelines/
    • GLA Guidelines
    • Needlestick Injury
    • TB Isolation
  • Susceptibilities/
  • ID fellow resources/
  • Other/
    • Links
    • Board Review slides
    • Teaching Documents
February 18, 2021

New COVID-19 treatment update!

February 18, 2021/ VAGLA Antimicrobial Stewardship Team

Head on over to the “Guidelines” section of the website for our new COVID-19 treatment recommendations where we try to make sense of all the data on how to best utilize tocilizumab (and no longer recommend convalescent plasma).

February 18, 2021/ VAGLA Antimicrobial Stewardship Team/

VAGLA Antimicrobial Stewardship Team

  • COVID-19 treatment update!
  • New antibiogram!